SANGBO Past Earnings Performance
Past criteria checks 0/6
SANGBO has been growing earnings at an average annual rate of 71.8%, while the Chemicals industry saw earnings growing at 11.5% annually. Revenues have been declining at an average rate of 5.9% per year.
Key information
71.8%
Earnings growth rate
78.7%
EPS growth rate
| Chemicals Industry Growth | 13.9% |
| Revenue growth rate | -5.9% |
| Return on equity | -0.1% |
| Net Margin | -0.04% |
| Last Earnings Update | 31 Mar 2024 |
Revenue & Expenses Breakdown
How SANGBO makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Mar 24 | 62,843 | -28 | 12,110 | 1,844 |
| 31 Dec 23 | 66,157 | 438 | 10,687 | 2,021 |
| 30 Sep 23 | 66,620 | -432 | 10,220 | 2,756 |
| 30 Jun 23 | 64,818 | 460 | 10,032 | 2,645 |
| 31 Mar 23 | 65,490 | 1,956 | 9,482 | 2,475 |
| 31 Dec 22 | 67,412 | 4,003 | 9,436 | 2,470 |
| 30 Sep 22 | 25,884 | 10,757 | 6,054 | 2,288 |
| 30 Jun 22 | 43,306 | 10,338 | 5,671 | 2,238 |
| 31 Mar 22 | 56,828 | 5,262 | 6,470 | 2,268 |
| 31 Dec 21 | 72,389 | 4,069 | 7,472 | 2,178 |
| 30 Sep 21 | 131,736 | 1,951 | 10,192 | 2,251 |
| 30 Jun 21 | 137,893 | -269 | 10,481 | 2,168 |
| 31 Mar 21 | 134,936 | 4,195 | 9,054 | 2,395 |
| 31 Dec 20 | 130,114 | 3,226 | 8,367 | 2,417 |
| 30 Sep 20 | 177,057 | 834 | 11,116 | 2,558 |
| 30 Jun 20 | 151,812 | -2,128 | 10,959 | 2,806 |
| 31 Mar 20 | 135,818 | -9,128 | 11,429 | 2,629 |
| 31 Dec 19 | 118,221 | -10,361 | 10,467 | 2,697 |
| 30 Sep 19 | -8,735 | -21,111 | 7,974 | 2,597 |
| 30 Jun 19 | 14,891 | -32,072 | 8,434 | 2,588 |
| 31 Mar 19 | 34,617 | -32,612 | 11,205 | 2,404 |
| 31 Dec 18 | 52,698 | -31,350 | 11,469 | 2,461 |
| 30 Sep 18 | 126,120 | -17,649 | 10,884 | 2,133 |
| 30 Jun 18 | 126,644 | -4,893 | 11,007 | 1,608 |
| 31 Mar 18 | 127,917 | -1,852 | 9,020 | 1,320 |
| 31 Dec 17 | 127,780 | -5,880 | 10,671 | 1,070 |
| 30 Sep 17 | 133,426 | -14,860 | 12,114 | 1,365 |
| 30 Jun 17 | 136,313 | -19,304 | 13,621 | 1,648 |
| 31 Mar 17 | 139,239 | -20,251 | 15,964 | 2,059 |
| 31 Dec 16 | 151,682 | -20,257 | 16,252 | 2,201 |
| 30 Sep 16 | 166,336 | -16,353 | 18,039 | 2,163 |
| 30 Jun 16 | 170,687 | -10,723 | 20,495 | 1,657 |
| 31 Mar 16 | 177,325 | -9,426 | 18,829 | 1,885 |
| 31 Dec 15 | 178,636 | -5,220 | 19,097 | 2,148 |
| 30 Sep 15 | 175,565 | -5,720 | 20,714 | 1,960 |
| 30 Jun 15 | 189,906 | -5,590 | 20,192 | 1,960 |
| 31 Mar 15 | 206,912 | -11,700 | 22,108 | 1,569 |
| 31 Dec 14 | 226,913 | -10,503 | 23,256 | 1,349 |
| 30 Sep 14 | 243,195 | -3,838 | 22,904 | 1,460 |
| 30 Jun 14 | 244,994 | -2,908 | 22,436 | 1,460 |
| 31 Mar 14 | 236,494 | 7,747 | 23,640 | 886 |
| 31 Dec 13 | 220,831 | 8,801 | 24,240 | 460 |
| 30 Sep 13 | 222,518 | 7,395 | 25,063 | 0 |
Quality Earnings: A027580 is currently unprofitable.
Growing Profit Margin: A027580 is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: A027580 is unprofitable, but has reduced losses over the past 5 years at a rate of 71.8% per year.
Accelerating Growth: Unable to compare A027580's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: A027580 is unprofitable, making it difficult to compare its past year earnings growth to the Chemicals industry (-17.5%).
Return on Equity
High ROE: A027580 has a negative Return on Equity (-0.13%), as it is currently unprofitable.